Other
Total
Moderna Total increased by 0.4% to $5.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $6.78B to $5.56B. Over 5 years (FY 2020 to FY 2025), Total shows an upward trend with a 16.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
Changes reflect shifts in the cost basis of the investment portfolio due to purchasing or selling activity.
Detailed definition
The amortized cost basis of debt securities classified as available-for-sale, excluding primary categories. This represe...
Peer comparison
Commonly reported by insurers with large fixed-income portfolios.
Metric ID:
other_available_for_sale_debt_securities_amortized_cost_basisHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.60B | $9.81B | $10.77B | $14.51B | $15.56B | $14.53B | $15.48B | $13.27B | $11.10B | $10.18B | $10.52B | $10.23B | $8.43B | $7.58B | $7.61B | $6.78B | $6.23B | $5.51B | $5.53B | $5.56B |
| QoQ Change | — | +48.6% | +9.9% | +34.7% | +7.3% | -6.7% | +6.6% | -14.3% | -16.3% | -8.3% | +3.3% | -2.7% | -17.6% | -10.1% | +0.5% | -11.0% | -8.1% | -11.5% | +0.4% | +0.4% |
| YoY Change | — | — | — | — | +135.9% | +48.1% | +43.7% | -8.6% | -28.7% | -29.9% | -32.0% | -22.9% | -24.0% | -25.6% | -27.6% | -33.8% | -26.1% | -27.3% | -27.3% | -18.0% |
Range$5.51B – $15.56B
CAGR-3.6%
Avg YoY Growth-6.5%
Median YoY Growth-25.9%
Current Streak2 quarters growth
Total at Other Companies
Frequently Asked Questions
- What is Moderna's total?
- Moderna (MRNA) reported total of $5.56B in Q1 2026.
- How has Moderna's total changed year-over-year?
- Moderna's total decreased by 18.0% year-over-year, from $6.78B to $5.56B.
- What is the long-term trend for Moderna's total?
- Over 5 years (2020 to 2025), Moderna's total has grown at a 16.1% compound annual growth rate (CAGR), from $2.62B to $5.53B.
- What does total mean?
- The original cost of debt investments held for sale, adjusted for accounting amortization.